Back
#1
17.0%
Top 63%
8.7%
Top 2%
6.2%
Top 17%
6.2%
Top 49%
5.7%
Top 6%
5.7%
Top 38%
4.0%
Top 6%
3.7%
Top 5%
3.7%
Top 8%
1.3%
Top 14%
1.1%
Top 9%
1.1%
Top 11%
0.7%
Top 30%
0.7%
Top 34%
0.7%
Top 9%
0.7%
Top 14%
0.7%
Top 22%
0.7%
Top 22%
0.7%
Estimating the prevalence of late-onset Fabry disease in the US in 2024
2024-12-14
public and global health
Title + abstract only
View on medRxiv
Show abstract
Fabry disease is a rare lysosomal storage condition in which sphingolipid levels build up to harmful levels in various bodily organs, eventually leading to life-threatening complications such as stroke and kidney failure. Fabry disease is caused by rare pathogenic alleles in the GLA gene on chromosome X and may present as an early or late-onset disease depending on the identity of the causal allele and the severity of its effect on the gene product. Epidemiological studies have widely varied in ...
Predicted journal destinations
1
Genome Medicine
56 training papers
2
PLOS ONE
1737 training papers
3
Genetics in Medicine
57 training papers
4
Nature Communications
483 training papers
5
Scientific Reports
701 training papers
6
eLife
262 training papers
7
BMJ Open
553 training papers
8
BMC Medicine
155 training papers
9
The American Journal of Human Genetics
77 training papers
10
Nature Medicine
88 training papers
11
PLOS Medicine
95 training papers
12
International Journal of Epidemiology
65 training papers
13
Nature Genetics
72 training papers
14
BMC Public Health
148 training papers
15
Frontiers in Public Health
135 training papers
16
Communications Medicine
63 training papers
17
iScience
74 training papers
18
Proceedings of the National Academy of Sciences
100 training papers
19
npj Digital Medicine
85 training papers